Most companies in the microbiome space have focused on recurrent, deadly C. difficile bacterial infections.
But microbes may also be able to help treat a common and pernicious condition called bacterial vaginosis, according to a new study.
Women with the condition who inserted a powder made from a single type of bacteria, Lactobacillus crispatus, directly into their vaginas, saw their condition return about 30% of the time, down from the control group’s rate of 45%. That treatment, called Lactin-V, is the product of nearly two decades of work by California-based Osel, Inc.
About the Author Reprints
